Releases
CVAC
2.330
+0.87%
0.020
  • All
  • Financials
  • Insiders
More
Webull provides the latest Curevac B.V. (CVAC) stock and general news. This information may help you make smarter investment decisions.
About CVAC
CureVac AG is a clinical-stage biopharmaceutical company, The Company strives to create transformative medicines to protect and improve people’s lives. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.